Free Trial
OTCMKTS:LSACU

LifeSci Acquisition (LSACU) Stock Price, News & Analysis

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)
Free LSACU Stock Alerts
Compare
Today's Range
N/A
50-Day Range
$21.75
▼
$21.75
52-Week Range
N/A
Volume
2,600 shs
Average Volume
11,483 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About LifeSci Acquisition

LifeSci Acquisition Corp. does not have significant operations. It intends to acquire assets or businesses through a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses in the biopharma, medical technology, digital health, and healthcare services sectors. The company was founded in 2018 and is based in New York, New York.

LSACU Stock News Headlines

April 9, 2024 | tmcnet.com
Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD
December 5, 2022 | tmcnet.com
Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength
April 27, 2024 | Prosper Trading Academy (Ad)
This AI Trade Machine Made 1,729%* (With 89% Wins)
This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?
September 17, 2022 | finance.yahoo.com
PMV Consumer Acquisition Corp. Announces Postponement of Special Meeting of Stockholders
See More Headlines
Receive LSACU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeSci Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
Shell Companies
Sub-Industry
N/A
Current Symbol
OTCMKTS:LSACU
CUSIP
N/A
CIK
N/A
Web
www.lifesciacquisition.com
Phone
646-889-1200
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Andrew Ian McDonald Ph.D. (Age 46)
    Chairman & CEO
  • Mr. David Dobkin (Age 41)
    CFO, Head of Strategy & Director
  • Mr. Michael Yehuda Rice (Age 55)
    COO & Director

Key Competitors

View All Competitors

LSACU Stock Analysis - Frequently Asked Questions

How do I buy shares of LifeSci Acquisition?

Shares of LSACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LSACU) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
They say it’s ‘unstoppable’ – How I made 43,509%
Investing Daily
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders